Research reference
Deltorphin II
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Deltorphin II →Peptide directory
Find a peptide
Public profiles inside a larger governed registry
Search by peptide name, brand, or research code. Open a full evidence profile or the published sources available for a record still in development. Source publication does not mean a completed scientific appraisal.
The registry is an expanding catalog, not a complete list of every peptide. A missing public result does not mean no research exists.
Published profiles
Search profiles and sources
Venom-derived natriuretic peptide
Dendroaspis natriuretic peptide
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Dendroaspis natriuretic peptide →Snake-venom peptide/protein toxin
Dendrotoxin I
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Dendrotoxin I →Antimicrobial peptide
Dermaseptin B2
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Dermaseptin B2 →Endogenous antimicrobial peptide precursor/product family
Dermcidin
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Dermcidin →Endogenous antimicrobial peptide
Dermcidin-1L
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Dermcidin-1L →IGF-1 peptide/protein analog
Des(1-3) IGF-1
Published sources available; full evidence profile in development.
1 published source records. Source publication does not imply scientific appraisal.
Open sources for Des(1-3) IGF-1 →GnRH analog
Deslorelin
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Deslorelin →- Developing
Desmopressin is a synthetic analog of arginine vasopressin modified by deamination at position 1 and D-arginine at position 8. It preferentially activates renal V2 receptors, increasing collecting-duct water reabsorption through aquaporin-2 trafficking; V2-mediated endothelial release of von Willebrand factor and factor VIII underlies selected haemostatic uses. Clinical effects and risks differ materially by indication, dose, route, formulation, renal function, fluid intake, age, and concomitant medicines.
Evidence and record details
Evidence integrity map
Human 1Preclinical 0Durable IDs 7Open signals 2- Publication state
- Published profile
- Verified source records
- 26 source records verified
- Chemistry record
- Chemistry record on file
- Regulatory entries
- 2 published regulatory entries
- Research questions
- No open questions documented
- Evidence review date
- No documented human review recorded
Source verification checks records; it does not itself approve scientific conclusions.
Somatostatin-analog chelator conjugate
DOTATATE
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for DOTATATE →- Developing
Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist studied in type 2 diabetes. WPF organizes the available work by glycemic outcomes, cardiovascular outcomes, comparisons, and safety. Results depend on the population, comparator, dose, and follow-up period.
Evidence and record details
Evidence integrity map
Human 2Preclinical 0Durable IDs 6Open signals 1- Publication state
- Published profile
- Verified source records
- Evidence record in preparation
- Chemistry record
- No governed record published
- Regulatory entries
- No published regulatory entry on file
- Research questions
- No open questions documented
- Evidence review date
- No documented human review recorded
Source verification checks records; it does not itself approve scientific conclusions.
Endogenous opioid peptide
Dynorphin A
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Dynorphin A →Endogenous opioid peptide
Dynorphin B
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Dynorphin B →Kallikrein inhibitor peptide
Ecallantide
Published sources available; full evidence profile in development.
1 published source records. Source publication does not imply scientific appraisal.
Open sources for Ecallantide →GLP-1 receptor agonist peptide
Ecnoglutide
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Ecnoglutide →Synthetic dipeptide
ED peptide
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for ED peptide →Synthetic tripeptide
EDG peptide
Published sources available; full evidence profile in development.
1 published source records. Source publication does not imply scientific appraisal.
Open sources for EDG peptide →Somatostatin-analog chelator conjugate
Edotreotide
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Edotreotide →
How the public directory relates to the 500-record Master Registry
master registry transparency
500 master records, with governance status shown explicitly
501
Master records
467
Governed records
34
Review-deferred
458
Peptide acquisition eligible
9
Governed comparators
The master registry has 467 governed identities from 501 records. 34 remain review-gated. Nine governed records are scientific comparators, leaving 458 peptide identities in the source acquisition cohort. Database reconciliation is a separate step. The 51 profiles shown on this directory are a represented public-profile subset, not the size of the master registry. All 51 public profiles on this render reconcile to governed peptide identities in that registry; unknown, duplicate, deferred, or comparator identities fail closed instead of appearing publicly.
Explore the full Master Registry →What the profile status labels mean
Evidence, chemistry, and regulatory counts include only records that crossed the relevant public-publication gate. A zero means none published in that lane—not that nothing is known. “No governed record published” is a publication-state disclosure; internal or pending material may exist without appearing in public counts. Source verification, editorial publication, and accountable scientific appraisal are distinct states; a source count alone does not approve a scientific conclusion.
Recently updated public records
When each public profile record was last changed — not clinical or scientific activity.